Evidence map›Paper›PMID 27629939›Full record

ArticleScientific reports2016

Methylcrotonoyl-CoA carboxylase 1 potentiates RLR-induced NF-κB signaling by targeting MAVS complex.

Zhongying Cao, Zhangchuan Xia, Yaqin Zhou, Xiaodan Yang, Hua Hao, Nanfang Peng, Shi Liu, Ying Zhu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Neuroimmunometabolism: A New Pathological Nexus Underlying Neurodegenerative Disorders.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Role of Mitochondria in Viral Infections.Life (Basel, Switzerland) · 2021
    Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zhongying CaoState Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.
Zhangchuan XiaState Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.
Yaqin ZhouState Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.
Xiaodan YangState Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.
Hua HaoState Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.
Nanfang PengState Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.
Shi LiuState Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.
Ying ZhuState Key Laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA virus infections are detected by the RIG-I family of receptors, which signal through the adaptor molecule mitochondrial antiviral signaling (MAVS). MAVS then recruits the adaptor's tumor necrosis factor receptor-associated factor (TRAF) 3 and TRAF6, which in turn activate IRF3 and NF-κB, respectively, to induce interferons (IFNs) and inflammatory responses. Here we show that the biotin-containing enzyme methylcrotonoyl-CoA carboxylase 1 (MCCC1) enhances virus-induced, MAVS-mediated IFN and inflammatory cytokine expression through the NF-κB signaling pathway. MCCC1 knockdown strongly inhibits induction of IFNs and inflammatory cytokines. Furthermore, MCCC1 shows extensive antiviral activity toward RNA viruses, including influenza A virus, human enterovirus 71, and vesicular stomatitis virus. Here, we have elucidated the mechanism underlying MCCC1-mediated inhibition of viral replication. MCCC1 interacts with MAVS and components of the MAVS signalosome and contributes to enhanced production of type I IFNs and pro-inflammatory cytokines by promoting phosphorylation of the IκB kinase (IKK) complex and NF-κB inhibitor-α (IκBα), as well as NF-κB nuclear translocation. This process leads to activation of IFNs and cytokine expression and subsequent activation of IFN-stimulated genes, including double-stranded RNA-dependent protein kinase PKR and myxovirus resistance protein 1. These findings demonstrate that MCCC1 plays an essential role in virus-triggered, MAVS-mediated activation of NF-κB signaling.

Indexed as

Signal TransductionA549 CellsAdaptor Proteins, Signal TransducingAntiviral AgentsCarbon-Carbon LigasesCell NucleusCytokinesDEAD Box Protein 58Gene Knockdown TechniquesHumansInflammation MediatorsInterferon Type INF-kappa BNF-KappaB Inhibitor alphaPhosphorylationProtein TransportAdaptor Proteins, Signal TransducingAntiviral AgentsCarbon-Carbon LigasesCytokinesDEAD Box Protein 58Inflammation MediatorsInterferon Type IMAVS protein, humanmethylcrotonoyl-CoA carboxylaseNF-kappa BNF-KappaB Inhibitor alphaRNA, Small InterferingTNF Receptor-Associated Factor 6

Identifiers

PMID27629939
PMCPMC5024325
OpenAlexW2519168054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.